EVENITY DIN 02489597
Health Canada record
| Active ingredient(s) | ROMOSOZUMAB 105 MG |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous |
| Schedule | PRESCRIPTION; SCHEDULE D |
| Class | Human |
| ATC | M05BX06 ROMOSOZUMAB |
| Original market date | 12-Aug-2019 |
| Current status date | 12-Aug-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Amgen Canada Inc — licence 100048, currently licensed, last inspection rating C (2023-03-01).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 22291 | 2019-06-17 | New Drug Submission (NDS) |